BeStock  
Stocks › Biotechnology › PGEN

Precigen PGEN

US equityMarket cap rank #2555Biotechnology
$7.74 −$0.80 (-9.37%)
Pre-market · Oct 6, 4:10 am ET · After hours $7.80 +0.76%
Open$8.51
Prev close$8.54
Day range$7.55 – $8.60
Volume10.25M
Market cap$2.77B
P/E (TTM)–
Dividend yield–

PGEN Stock News

Headlines matching Precigen or the PGEN ticker, most recent first.

  • B. Riley Securities Initiates Precigen(PGEN.US) With Buy Rating, Announces Target Price $12Market news · 25 Sep 2026
  • B. Riley Securities Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $12Market news · 25 Sep 2026
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $18Market news · 5 Aug 2026
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $14Market news · 3 Aug 2026
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $14Market news · 28 May 2026
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $11Market news · 14 May 2026
  • Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $11Market news · 14 May 2026
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $10Market news · 2 Apr 2026
  • Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $9Market news · 26 Mar 2026
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $10Market news · 26 Mar 2026
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $18Market news · 1 Oct 2026
  • H.C. Wainwright Keeps Their Buy Rating on Precigen (PGEN)TipRanks · 1 Oct 2026
  • Cantor Fitzgerald Maintains Precigen(PGEN.US) With Buy RatingMarket news · 26 Sep 2025
  • Citizens JMP Maintains Precigen(PGEN.US) With Buy Rating, Raises Target Price to $8Market news · 19 Aug 2025
  • H.C. Wainwright Maintains Precigen(PGEN.US) With Buy Rating, Maintains Target Price $8.5Market news · 19 Aug 2025

Discussion

No comments yet — be the first to weigh in on PGEN.

Leave a comment

Scroll to Top